In recent years, phage therapy has experienced a rise in scientific interest, more widespread media coverage and an injection of investment. To drive the field further forward, phage therapy developers are continuously looking for the most innovative service providers involved in sequencing, manufacturing, cell media provision, clinical research organization and IP advice.
The 2nd Bacteriophage Therapy Summit is the perfect opportunity to demonstrate your technology, expertise and capacity to meet the increasing demands of this re-emerging field.
Benefit from Market Intelligence
The field of phage therapy opens opportunity to target antibiotic-resistant bacteria in multiple therapeutic contexts. Hear how biotech companies are looking for services and solutions to facilitate their R&D platforms and match your solutions accordingly.
Gain the Trust of Drug Developers
With the re-emergence of biotech companies focused on phage therapy, followed by interest from large pharma and investors, this meeting is a dedicated platform for you to get your products in front of our dedicated audience and position yourself as an essential partner for success.
Generate New Business Leads
With a room full of pioneering drug developers focusing on translating bacteriophage research into effective therapeutics, secure valuable face time with key decision-makers during speed networking and pre-organized 1-2-1 meetings.
Raise Brand Awareness
Increase market share through pre-conference and at-event advertizing to phage developers. Differentiate your discovery, pre-clinical and translational services from other solution providers that cater to the phage community.
Exemplify the Capabilities of Your Solution
Demonstrate your innovative products and services in our high-traffic networking area and exhibition room to give customers a hands-on insight into your capabilities that can help accelerate phage therapy product development.